Современная онкология (Jun 2018)

Case studies on clinical experience of targeted therapy ribociclib in combination with letrozole in patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer

  • M A Frolova,
  • Ya I Kochetkova,
  • V A Chubenko,
  • N M Volkov,
  • F V Moiseenko,
  • T V Garmarnik,
  • D M Ponomarenko,
  • A E Orlov,
  • Yu V Kostalanova,
  • Yu Yu Makarycheva,
  • A A Nizegorodzeva

DOI
https://doi.org/10.26442/1815-1434_2018.2.29-37
Journal volume & issue
Vol. 20, no. 2
pp. 29 – 37

Abstract

Read online

The article represents case studies on clinical experience of targeted therapy ribociclib in combination with letrozole in patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer in Russian Federation. Russian oncologists’ experience has demonstrated the high efficacy and manageable safety profile of the ribociclib treatment in patients in clinical practice.

Keywords